(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

Tianjin Chempharmatech. Co., Ltd., established in 2012 and based in the Tianda Science and Technology Park in Binhai New Area, Tianjin, manufactures pharmaceutical intermediates and fine chemicals, with a portfolio built around complex multi-step synthesis routes for drugs such as Avibactam Sodium Salt (offering numerous named intermediates along its synthesis pathway), Ezetimibe, Posaconazole, Dabigatran etexilate, Alogliptin, Tedizolid phosphate, and antibody-drug conjugate payload/linker building blocks including MMAE and its associated tripeptide and dipeptide intermediates. The company offers CMO contract manufacturing, ships on FOB, CFR, CIF, and CIP terms with T/T payment, and sells across North America, Western Europe, Asia, Central/South America, Eastern Europe, Australasia, the Middle East, and Africa.